Fibroblast Heterogeneity and its Role in Keloid Pathogenesis Implication for targeted drug development

  • Home
  • Fibroblast Heterogeneity and its Role in Keloid Pathogenesis Implication for targeted drug development

Fibroblast Heterogeneity and its Role in Keloid Pathogenesis Implication for targeted drug development

Jong Hee Lee, MD, PhD

Article Type: Conference Abstract

Download PDF File

METRICS

Fibroblast Heterogeneity and its Role in Keloid Pathogenesis Implication for targeted drug development 

Views: 503

Email Article

Jong Hee Lee, MD, PhD

  1. Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  2. Department of Medical Device Management & Research, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Republic of Korea.

Running Title

Fibroblast Heterogeneity and its Role in Keloid pathogenesis Implication for targeted drug development

Word Count

220 words

The full text of this article is for subscribers. The title and abstract remain free to read.

View subscription plans Log in Create an account

Our Scientific Partners

© 2011-2026 Keloid Research Foundation, New York - ISSN 24751081 (Print) - ISSN 2475109X (Online)